Altered Pituitary Gland Structure and Function in Posttraumatic Stress Disorder

Por Cooper, Odelia, Bonert, Vivien, Moser, Franklin, Mirocha, James, Melmed, Shlomo
Publicado no J Endocr Soc (2017)

SUN-461 Predictors of Early and Late Hyponatremia after Pituitary Surgery

Por Cooper, Odelia, Hwe, Jennifer, Puchalski, Adam, Bonert, Vivien, Mamelak, Adam
Publicado no J Endocr Soc (2019)

SUN-442 EGFR/ErbB2 Targeted Therapy for Aggressive Prolactinomas

Por Cooper, Odelia, Bonert, Vivien, Rudnick, Jeremy, Pressman, Barry, Melmed, Shlomo
Publicado no J Endocr Soc (2019)

Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas

Por Biller, Beverly MK, Colao, Annamaria, Petersenn, Stephan, Bonert, Vivien S, Boscaro, Marco
Publicado em 2010

Acromegaly Clinical Trial Methodology Impact on Reported Biochemical Efficacy Rates of Somatostatin Receptor Ligand Treatments: A Meta-Analysis

Por Carmichael, John D., Bonert, Vivien S., Nuño, Miriam, Ly, Diana, Melmed, Shlomo
Publicado em 2014

Silent Corticogonadotroph Adenomas: Clinical and Cellular Characteristics and Long-Term Outcomes

Por Cooper, Odelia, Ben-Shlomo, Anat, Bonert, Vivien, Bannykh, Serguei, Mirocha, James, Melmed, Shlomo
Publicado em 2010

Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly

Por Salvatori, Roberto, Nachtigall, Lisa B., Cook, David M., Bonert, Vivien, Molitch, Mark E., Blethen, Sandra, Chang, Stephen
Publicado em 2009

A Structural and Functional Acromegaly Classification

Por Cuevas-Ramos, Daniel, Carmichael, John D., Cooper, Odelia, Bonert, Vivien S., Gertych, Arkadiusz, Mamelak, Adam N., Melmed, Shlomo
Publicado no J Clin Endocrinol Metab (2015)

Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors

Por Cooper, Odelia, Mamelak, Adam, Bannykh, Serguei, Carmichael, John, Bonert, Vivien, Lim, Stephen, Cook-Wiens, Galen, Ben-Shlomo, Anat
Publicado em 2013

The association between biochemical control and cardiovascular risk factors in acromegaly

Por Carmichael, John D., Broder, Michael S., Cherepanov, Dasha, Chang, Eunice, Mamelak, Adam, Said, Qayyim, Neary, Maureen P., Bonert, Vivien
Publicado no BMC Endocr Disord (2017)

Long-term treatment outcomes of acromegaly patients presenting biochemically-uncontrolled at a tertiary pituitary center

Por Carmichael, John D., Broder, Michael S., Cherepanov, Dasha, Chang, Eunice, Mamelak, Adam, Said, Qayyim, Neary, Maureen P., Bonert, Vivien
Publicado no BMC Endocr Disord (2017)

MON-459 ONO-5788, a Novel Oral Small Molecule Somatostatin Receptor Type-2 (SST2) Agonist, Attenuates GH Hypersecretion in Human GH-Secreting, Pituitary Adenoma-Derived Cells

Por Zhou, Cuiqi, Bonert, Vivien, Mamelak, Adam, Kelly, Daniel, Barkhoudarian, Garni, Hoon, Dave, Komagata, Tatsuya, Shinozaki, Koji, Melmed, Shlomo
Publicado no J Endocr Soc (2019)